NIH-funded research NIH-funded research

One MRI scan that measures liver fat, iron, and scarring

Official title: Project 3: A Novel Simultaneous Multiparametric MRI Approach for the Quantitative Assessment of Non-alcoholic Fatty Liver Disease

Funded at University of Hawaii at Manoa · NIH-11372037 · Data updated 2026-11-12

A new MRI method uses a single scan to measure liver fat, iron, and scarring for people with nonalcoholic fatty liver disease.

More Fatty Liver research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Hawaii at Manoa
NIH-funded
Lab location1 site (Honolulu, United States)
Project startMarch 20, 2022
Project endJanuary 31, 2027
Funding year2026
Award (this year)$373,372
NIH project number5P20GM139753-05
Project IDNIH-11372037 on NIH RePORTER

Who could benefit from this research

Could help

Adults with suspected or diagnosed nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) who can safely undergo MRI scans.

Less likely to help

People with MRI-incompatible implants, severe claustrophobia, or liver disease unrelated to NAFLD may not be eligible or benefit from this approach.

What this research studies

If you have nonalcoholic fatty liver disease, this project uses a single, fast MRI scan to capture several measurements at once—fat content, iron levels, and tissue stiffness linked to scarring. The researchers combine different MRI techniques simultaneously to produce quantitative maps of the liver without routine biopsy. They will compare these MRI results to current standards like magnetic resonance elastography and, when available, biopsy findings to check accuracy. Over time this could allow doctors to track disease progression or response to lifestyle changes and treatments using repeat imaging.

Why it matters

Potential benefit: If successful, this could provide accurate, noninvasive measures of liver damage and reduce the need for biopsy.

How similar studies have gone: Related MRI tools such as magnetic resonance elastography and MRI proton-density fat fraction have shown promise, but combining multiple quantitative measures in one simultaneous scan is a newer approach.

Where this research is happening

  • University of Hawaii at Manoa
    Honolulu, United States
    Active

Researchers

  • Principal investigator: Rettenmeier, Christoph Alexander — University of Hawaii at Manoa
  • Study coordinator: Rettenmeier, Christoph Alexander

Related research

Other NIH-funded projects on the same topics.

  • Role of fat droplets in liver fat and inflammatory signals in NAFLD

    A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11623263

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

  • How the TET1 gene affects non-alcoholic fatty liver disease

    Researchers are looking at whether changes in the TET1 gene and DNA 'tagging' (methylation) play a role in adult non-alcoholic fatty liver disease.

    NIH research State University New York Stony Brook · Stony Brook, United States · NIH-11447065

  • Hepatocellular Genetic Clues for Fatty Liver in Hispanic Adults

    A large NIH grant helps researchers study why fatty liver develops in Hispanic adults and how genetics interact with lifestyle to affect risk.

    NIH research University of Texas Rio Grande Valley · Edinburg, United States · NIH-11421441

  • Toxic fats, vitamin B12 loss, and AHR may drive fatty liver disease

    This grant looks at how certain environmental chemicals may trigger liver damage linked to fatty liver disease and how a vitamin found in the blood could be affected.

    NIH research Michigan State University · East Lansing, United States · NIH-11398883

  • Glutamine and T cells in fatty liver disease

    A study explores how liver glutamine levels affect inflammatory CD4+ T cells in fatty liver disease to find potential new ways to reduce liver inflammation.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11388863

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.